Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : The ENRON Scandal -- Ignore unavailable to you. Want to Upgrade?

To: Baldur Fjvlnisson who wrote (4245)	7/8/2002 2:19:33 PM
From: Mephisto	Read Replies (1) \| Respond to of 5185

And then there is the MERCK PROBLEM: Merck Leads Declines in Pre-Open Trading Mon Jul 8, 9:02 AM ET NEW YORK (Reuters) - Stocks slumped in early trading on Monday, led by Merck & Co. after news the drugmaker recorded revenue of more than $14 billion from its pharmacy-benefits subsidiary Medco that the unit never actually collected. Merck fell to $46.50 on Instinet, from a close at $48.86 on Friday, but up from earlier trades at $45.50 on Instinet and was the electronic trading system's most-active stock. The information was contained in a Merck filing with the Securities and Exchange Commission ( news - web sites). story.news.yahoo.com